
1. malar j. 2017 apr 19;16(1):155. doi: 10.1186/s12936-017-1816-x.

molecular surveillance plasmodium falciparum drug resistance republic
of congo: four nine years introduction artemisinin-based
combination therapy.

koukouikila-koussounda f(1), jeyaraj s(2), nguetse cn(2), nkonganyi cn(2), kokou 
kc(2), etoka-beka mk(1), ntoumi f(1)(2), velavan tp(3)(4)(5)(6).

author information: 
(1)fondation congolaise pour la recherche médicale (fcrm), brazzaville, republic 
of congo.
(2)institute tropical medicine, university tübingen, tübingen, germany.
(3)fondation congolaise pour la recherche médicale (fcrm), brazzaville, republic 
of congo. velavan@medizin.uni-tuebingen.de.
(4)institute tropical medicine, university tübingen, tübingen, germany.
velavan@medizin.uni-tuebingen.de.
(5)duy tan university, da nang, vietnam. velavan@medizin.uni-tuebingen.de.
(6)vietnamese-german centre medical research, hanoi, vietnam.
velavan@medizin.uni-tuebingen.de.

background: resistance anti-malarial drugs hinders efforts malaria
elimination eradication. following global spread chloroquine-resistant
parasites, republic congo adopted artemisinin-based combination therapy
(act) 2006 first-line treatment uncomplicated malaria. assess 
impacts implementation act, molecular surveillance anti-malarial
drug resistance conducted congo 4 9 years introduction of
act.
methods: blood samples 431 febrile children aged 1-10 years utilized from
two previous studies conducted 2010 (n = 311) 2015 (n = 120). samples 
were screened malaria parasites using nested pcr. direct sequencing used 
to determine frequency distribution genetic variants anti-malarial 
drug-resistant plasmodium falciparum genes (pfcrt, pfmdr1, pfatp6, pfk13) in
malaria-positive isolates.
results: one-hundred nineteen (n = 70 2010 n = 49 2015) samples
were positive p. falciparum. relative decrease proportion of
chloroquine-resistant haplotype (cviet) 100% 2005, 1 year the
introduction implementation act 2006, 98% 2010 71% 2015 was
observed. regarding multidrug transporter gene, considerable reduction in
the frequency mutations n86y (from 73 27%) d1246y (from 22 0%)
was observed. however, prevalence y184f mutation remained stable (49% 
in 2010 compared 54% 2015). isolates carrying pfatp6 h243y 25% in
2010 frequency reduced null 2015. none parasites
harboured pfk13 mutations associated prolonged artemisinin clearance 
southeast asia. nevertheless, 13 new pfk13 variants reported among the
investigated isolates.
conclusion: implementation act led decline prevalence of
chloroquine-resistant parasites republic congo. however, constant
prevalence pfmdr1 y184f mutation, associated lumefantrine
susceptibility, indicate selective drug pressure still exists. taken together, 
this study could serve basis epidemiological studies monitoring the
distribution molecular markers artemisinin resistance republic of
congo.

doi: 10.1186/s12936-017-1816-x 
pmcid: pmc5395861
pmid: 28420403  [indexed medline]

